Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic

Product Details
Customization: Available
Type: Pharmaceutical Intermediates
Appearance: Crystal
Still deciding? Get samples of US$ 500/kg
Request Sample
Manufacturer/Factory & Trading Company
Diamond Member Since 2023

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Years of Export Experience
The export experience of the supplier is more than 10 years
Experienced Team
The supplier has 20 foreign trading staff(s) and 16 staff(s) with over 6 years of overseas trading experience
to see all verified strength labels (30)
  • Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic
  • Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic
  • Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic
  • Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic
  • Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic
  • Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic
Find Similar Products
  • Overview
  • Product Description
  • Detailed Photos
  • Product Parameters
  • Packaging & Shipping
  • Company Profile
  • Our Advantages
  • FAQ
Overview

Basic Info.

Model NO.
CAS 7778-77-0
Quality
Refined
Colour
White
Molecular Weight
136.09
Registration Number
Y20190008050
Registration State
a
Purity
99%
Transport Package
Carton
Specification
25kg/bag
Trademark
Huaren
Origin
China
Production Capacity
100000

Product Description

Product Description
Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic
Drug name: 
Potassium Phosphate Monobasic

Type of product:
Raw drug substance

Indications: 
The product can be used to treat and prevent hypovolemia, acute normovolemic hemodilution (ANH).

About Potassium Phosphate Dibasic:
It is mainly used in total parenteral nutrition therapy as a supplement for phosphorus and potassium.

 

Detailed Photos
Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic
Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic
Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic

 

Product Parameters
Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic
Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic

 

Product features: 

1) The 2018 version of national essential medicine, the only blood volume expander included

2) Guidelines and consensus recommendations, only for children

3) It has no plasma accumulation and little effect on renal function

4) The expansion effect is good

5) Compared with gelatin products, the allergic reaction rate is lower, the volume expansion effect is 4-6 hours, can be used in children

6) Selection of natural waxy corn, more stringent quality control
Applicable departments: 

The first department of anesthesiology, other departments include surgical surgery (orthopedics, neurosurgery, general surgery, etc.), other bleeding departments (emergency department, obstetrics and gynecology, etc.)
 
Packaging & Shipping

Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic

Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic
Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic
Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic

 

Company Profile
Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic

ABOUT US

Founded in May 1998, Huaren Pharmaceutical is a modern pharmaceutical and health industry group integrating R&D, production and sales, focusing on medicine, health, medical equipment and medical services.

In August 2010, the company was successfully listed on the Shenzhen Stock Exchange, the stock abbreviation is "Huaren Pharmaceutical", stock code "300110". In July 2019, the company underwent a change of shareholding, and the management committee of Xi'an Qujiang New Area became the actual controller of the company.

After more than 20 years of development, the company's business focuses on nephrology, respiratory, fine hemp and large-volume preparations and other fields, and has successively built five production bases in Qingdao, Rizhao, Xiaogan, Pubei and Hefei, with a total production capacity of 950 million bags (bottles), and all production lines have passed the new GMP certification. The company's main products include small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices, tablets, capsules, powders, granules, supporting drug packaging, health products and APIs, etc., with a total of 98 varieties and 212 specifications of existing drugs, realizing the integrated development of "raw materials + preparations + pharmaceutical packaging materials".

 

Our Advantages
Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic
Raw Materials Medicine API CAS 7778-77-0 Potassium Phosphate Monobasic

Taking innovation as the soul of development, in recent years, the company actively grasps the strategic development opportunities, focuses on the treatment direction of nephrology, respiratory medicine, precision and anaesthesiology, as well as the screening of new varieties such as large-volume preparations, and targets the world-class enterprises at home and abroad, continuously increases research and development investment, enrich the research and development pipeline, enrich the product line, and enhance the ability of sustainable development. By the end of 2023, Huayen Pharmaceutical and its subsidiaries had obtained 508 authorized patents, including 103 invention patents. Among them, the wholly-owned subsidiary Xingxing Pharmaceutical is one of the 50 designated manufacturers of class II psychotropic drug raw materials in China. Among them, the market share of peritoneal dialysate products ranked first among domestic brands.

Through more than 20 years of exploration and practice, the company has won a series of honors such as "National key technology transformation 'double high and one Excellent' project", "National Intellectual Property Advantage Demonstration Enterprise", "Shandong Pharmaceutical Industry Excellence Enterprise in the 60th anniversary of the founding of the People's Republic of China", "Shandong Quality Management Award", "Shandong famous Brand Product", "Shandong Executive Brand Cultivation Enterprise", "Respiratory system outstanding product brand" and so on. In 2020, the company won the honorary title of "2020 National market Quality Credit AA level (customer satisfaction Enterprise)" issued by the China Quality Association. In 2022, the company won the "May Day Labor Award of Shandong Province". In 2024, it was ranked 71 in the "Top 100 Chinese Pharmaceutical Industry" for five consecutive years.

FAQ
Q1- Which payment terms are you accept?
A: T/T or lrrevocable L/C at sight.
Q2- How do you ship the order normally?
A: We can ship goods by sea, by train or by air.
Q3- Can the packaging be customized?
A: Yes, we accept packaging customization service.



 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier